Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

7.92

-0.13 (-1.61%)

At close: May 22, 2026, 4:00 PM EDT

8.06

+0.14 (1.77%)

After-hours: May 22, 2026, 7:21 PM EDT

Seres Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29.83	45.77	30.79	127.97	163.03	180
Short-Term Investments	-	-	-	-	18.31	110.7
Cash & Short-Term Investments	29.83	45.77	30.79	127.97	181.34	290.71
Cash Growth	-49.30%	48.63%	-75.94%	-29.43%	-37.62%	14.62%
Accounts Receivable	0.23	0.16	-	-	-	-
Other Receivables	-	0.36	2.07	-	-	-
Total Trade Receivables	0.23	0.52	2.07	-	-	-
Other Current Assets	1.77	3.09	5.81	47.45	13.42	12.92
Total Current Assets	31.84	49.38	38.67	175.41	194.76	303.63
Net Property, Plant & Equipment	77.08	80.12	92.44	108.03	133.97	36.15
Long-Term Investments	-	-	-	-	-	0.5
Other Long-Term Assets	8.7	8.7	8.7	75.16	20.05	14.59
Total Assets	117.62	138.19	139.81	358.6	348.78	354.86
Accounts Payable	2.34	1.68	4.08	3.64	17.44	13.74
Accrued Expenses	6.14	7.25	28.47	22.51	59.84	45.09
Current Portion of Long-Term Debt	-	-	-	-	0.46	-
Current Portion of Leases	10.87	10.39	8.67	5.59	3.6	6.61
Unearned Revenue	-	-	-	-	4.26	16.82
Other Current Liabilities	-	-	-	66.92	-	-
Total Current Liabilities	19.34	19.32	41.22	98.66	85.6	82.26
Long-Term Debt	-	-	-	101.54	50.59	24.64
Long-Term Leases	69.63	72.58	82.97	91.65	107.94	17.96
Other Long-Term Liabilities	2.14	2.08	1.84	111.6	93.87	98.49
Total Long-Term Liabilities	71.78	74.65	84.8	304.8	252.41	141.09
Total Liabilities	91.12	93.98	126.03	403.46	338	223.35
Common Stock	0.01	0.01	0.01	0.14	0.13	0.09
Additional Paid-in Capital	1,019	1,017	991.87	933.24	875.18	745.83
Accumulated Other Comprehensive Income	-	-	-	-	-0.01	-0.06
Retained Earnings	-992.32	-972.4	-978.1	-978.24	-864.51	-614.35
Shareholders' Equity	26.5	44.22	13.78	-44.86	10.78	131.51
Total Liabilities & Equity	117.62	138.19	139.81	358.6	348.78	354.86
Total Debt	80.5	82.97	91.64	198.78	162.59	49.21
Net Cash (Debt)	-50.67	-37.2	-60.85	-70.82	18.75	241.5
Net Cash Growth	-	-	-	-	-92.23%	13.46%
Net Cash Per Share	-5.58	-4.19	-7.83	-11.06	3.47	52.67
Book Value	26.5	44.22	13.78	-44.86	10.78	131.51
Book Value Per Share	2.92	4.99	1.77	-7.01	2.00	28.68
Tangible Book Value	26.5	44.22	13.78	-44.86	10.78	131.51
Tangible Book Value Per Share	2.92	4.99	1.77	-7.01	2.00	28.68

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q